Mfsd2a expression was highly elevated in NASH patients, evident from the intense plasma membrane staining of Mfsd2a in periportal hepatocytes that was absent in the non-NASH patients, with the exception of one patient who had moderate steatosis and inflammation (Figure 1D). This evidence concerns the gene MFSD2A and steatosis.